SMARCA2
protein-codingSWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2, the group of Bromodomain containing|BAF complex|GBAF complex
Gene summary
The protein encoded by this gene is a member of the SWI/SNF family of proteins and is highly similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. Alternatively spliced transcript variants encoding different isoforms have been found for this gene, which contains a trinucleotide repeat (CAG) length polymorphism. [provided by RefSeq, Jan 2014]
- SNF2L2
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~213.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0011053
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0011053
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0011053
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0011053
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0011053
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0011053
Submitter: ClinGen
*SMARCA2* was first reported in relation to autosomal dominant intellectual disability-sparse hair-brachydactyly syndrome, also known as Nicolaides-Baraitser syndrome, in 2012 (Van Houdt et al., PMID: 22366787). Numerous missense variants, all of which occur in highly conserved ATPase motifs, have been reported. Sixteen *de novo* missense variants that have been reported in 17 probands in 5 publications (PMIDs: 22366787, 22822383, 23906836, 25249037, 25724810) are included in this curation. The mechanism of pathogenicity is suggested to be dominant negative (PMIDs: 8871545, 22366787). Note that a few loss-of-function variants in *SMARCA2* have been identified in large neurodevelopmental disorder cohorts (e.g., PMID: 31112269), but the clinical features were not described in depth. Since it is unclear if loss-of-function variants cause the full clinical spectrum, they were not included in this curation. This gene-disease relationship is also supported by *in vitro* functional assays and cell culture models. In summary, there is definitive evidence supporting the relationship between *SMARCA2* and autosomal dominant intellectual disability-sparse hair-brachydactyly syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 18, 2020 (SOP Version 7).
Inheritance Pattern: AD
Disease ID:MONDO:0859139
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Craniofacial; Dental; Dermatologic; Gastrointestinal; Genitourinary; Musculoskeletal; Neurologic
Intervention: Allergy/Immunology/Infectious
Rationale: Among other features, the condition can involve recurrent respiratory infections, and awareness may allow preventative measures and early and aggressive treatment of infections
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SMARCA2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003070.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 19 | 287 | 13 | 319 | ||
| missense | 46 | 87 | 481 | 115 | 20 | 749 |
| nonsense | 1 | 19 | 20 | |||
| start loss | 0 | |||||
| frameshift | 1 | 10 | 2 | 13 | ||
| splice donor/acceptor (+/-2bp) | 1 | 18 | 2 | 21 | ||
| Total | 46 | 90 | 547 | 406 | 33 | 1122 |
Highest pathogenic variant AF is 0.000006571425
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003061.3 | 33 | MANE Select | |
| Ensembl | ENSP00000265773.5 | 33 | MANE Select | |
| RefSeq | NP_001276325.1 | 33 | Standard | |
| RefSeq | NP_001276326.1 | 32 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Thermogenesis - Homo sapiens (human)
- Hepatocellular carcinoma - Homo sapiens (human)
- Retinoblastoma (RB) in Cancer
- Pathways Affected in Adenoid Cystic Carcinoma
- VEGFA-VEGFR2 Signaling Pathway
Biological Process
- negative regulation of transcription by RNA polymerase II
- chromatin remodeling
- regulation of transcription, DNA-templated
- regulation of transcription by RNA polymerase II
- spermatid development
Molecular Function
- chromatin binding
- transcription coactivator activity
- helicase activity
- protein binding
- ATP binding
Cellular Component
- nuclear chromatin
- nucleus
- nucleoplasm
- SWI/SNF complex
- intracellular membrane-bounded organelle
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000382203
- Coding exons
- 33
- Length
- 178283
- Individuals with no LoFs
- 125579
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 168
- Defined
- 125748
- p
- 0.000672
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 5.05 | 476 | 904 | 0.527 | 0.0000535 | 10486 |
| Missense (PolyPhen) | 69 | 109.77 | 0.62859 | 1228 | ||
| Synonymous | -4.19 | 430 | 333 | 1.29 | 0.0000202 | 2955 |
| Loss of Function | 7.69 | 11 | 89.6 | 0.123 | 0.00000493 | 1020 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00028 | 0.00018 | rare |
| Latino/Admixed American | 0.00024 | 0.00020 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00017 | 0.00016 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00023 | 0.00020 | rare |
| South Asian | 0.0082 | 0.0043 | notable |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Component of SWI/SNF chromatin remodeling complexes that carry out key enzymatic activities, changing chromatin structure by altering DNA-histone contacts within a nucleosome in an ATP-dependent manner. Binds DNA non-specifically (PubMed:22952240, PubMed:26601204). Belongs to the neural progenitors-specific chromatin remodeling complex (npBAF complex) and the neuron-specific chromatin remodeling complex (nBAF complex). During neural development a switch from a stem/progenitor to a postmitotic chromatin remodeling mechanism occurs as neurons exit the cell cycle and become committed to their adult state. The transition from proliferating neural stem/progenitor cells to postmitotic neurons requires a switch in subunit composition of the npBAF and nBAF complexes. As neural progenitors exit mitosis and differentiate into neurons, npBAF complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C subunits in neuron-specific complexes (nBAF). The npBAF complex is essential for the self-renewal/proliferative capacity of the multipotent neural stem cells. The nBAF complex along with CREST plays a role regulating the activity of genes essential for dendrite growth (By similarity). {ECO:0000250|UniProtKB:Q6DIC0, ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.;
- Disease
- DISEASE: Nicolaides-Baraitser syndrome (NCBRS) [MIM:601358]: A rare disorder characterized by severe mental retardation with absent or limited speech, seizures, short stature, sparse hair, typical facial characteristics, brachydactyly, prominent finger joints and broad distal phalanges. Some of the features are progressive with time. {ECO:0000269|PubMed:22366787, ECO:0000269|PubMed:22426308, ECO:0000269|PubMed:23906836, ECO:0000269|PubMed:27665729}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Schizophrenia (SCZD) [MIM:181500]: A complex, multifactorial psychotic disorder or group of disorders characterized by disturbances in the form and content of thought (e.g. delusions, hallucinations), in mood (e.g. inappropriate affect), in sense of self and relationship to the external world (e.g. loss of ego boundaries, withdrawal), and in behavior (e.g bizarre or apparently purposeless behavior). Although it affects emotions, it is distinguished from mood disorders in which such disturbances are primary. Similarly, there may be mild impairment of cognitive function, and it is distinguished from the dementias in which disturbed cognitive function is considered primary. Some patients manifest schizophrenic as well as bipolar disorder symptoms and are often given the diagnosis of schizoaffective disorder. {ECO:0000269|PubMed:19363039}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.516
Intolerance Scores
- LoFtool
- 0.0940
- RVIS EVS
- -1.97
- RVIS percentile EVS
- 1.82
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.931
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |